Arvinas (NASDAQ:ARVN – Free Report) had its price objective decreased by Guggenheim from $57.00 to $32.00 in a research report sent to investors on Thursday morning,Benzinga reports. Guggenheim currently has a buy rating on the stock. A number of other research analysts also recently issued reports on the company. BMO Capital Markets set a $20.00 […]

Cardlytics (NASDAQ:CDLX – Free Report) had its target price cut by Evercore ISI from $4.00 to $3.00 in a report issued on Thursday morning,Benzinga reports. They currently have an in-line rating on the stock. Separately, Needham & Company LLC reiterated a “hold” rating on shares of Cardlytics in a research report on Thursday. One research […]